GP
RPTP

GLG Partners’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

GLG Partners’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-400,000
Closed -$3.59M – 538
2016
Q3 		$3.59M Buy
+400,000
New +$2.84M 0.11% 220

GLG Partners's RPTP Position: Q4 2016 in Review

GLG Partners sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 400,000 shares — an estimated $3.59M sold.

GLG Partners first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $3.59M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • GLG Partners reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • GLG Partners sold 400,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $3.59M.
  • GLG Partners first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • GLG Partners's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $3.59M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.